Biotechnology is hot! Let’s analyze the sizzle.

By November 1, 2013Uncategorized


By: Monique Carter.

Howdy from the Lone Star State fellow ‘The Transcript’ readers!  My name is Monique Carter.  I am super excited about being named a new writer for the Hopkins Biotech Network newsletter.  I look forward to sharing my many thoughts and opinions about a number of different biotechnology related topics.  You can look forward to reading various articles that range from biotechnology start-up company model analysis to the role of intellectual property rights in the enhancement of pricing and profitability of biotechnology companies.

Now, a bit more about me…

My introduction to the field of biotechnology came during my first semester of college at Baylor University.  I was not sitting in the front row of a large lecture hall or attending a deeply scientific talk in a lecture series; I was simply listening to a podcast on my iPod.  The podcast host eloquently described the historical race between industry and the government to sequence the human genome.  As the story unfolded, my scientific curiosity was piqued and there was no way that I could not be involved in a field that made what I thought impossible a reality!  It was at that time that I began to take steps to learn more about the cellular and biochemical processes that are strategically harnessed to characterize genes, cure diseases and increase human quality of life.  By the end of my senior year, I had gained three years of bench research experience, completed a number of research internships, presented my work at national conferences, and became the first natural sciences graduate in my family.

Since that time, I gained further experience as a bench scientist at the University of Texas Southwestern Medical Center and the National Institutes of Health-NHLBI.  I then transitioned into the drug development industry.    As a Senior Consultant and Manager for an oncology targeted therapy development facilitation firm, I was responsible for creating strategic life cycle management plans, competitive landscape analyses, and clinical development plans for pharmaceutical and biotechnology companies of all sizes.  I am currently a Senior Research Scientist for a pharmaceutical company in Dallas.  I am responsible for the translational research and patent portfolio development strategies for the company’s tyrosine kinase inhibitor pipeline.  I enrolled in the Johns Hopkins Master of Science in Biotechnology program earlier this year to gain the knowledge and confidence needed to embark on a sustainable bio-entrepreneurial venture in the near future.

In my spare time, I am an avid patient advocate.  I actively serve as an appointed addressing health disparities advisory panel member for the Patient-Centered Outcomes Research Institute (PCORI), a non-profit organization created by Congress under the Affordable Care Act.   Additionally, I co-founded the Rural Healthcare and Education Access Initiative (RHEAi), a non-profit organization that strives to deplete health disparities in rural communities through awareness. I also volunteer with Susan G Komen as a member of the Advocates in Science program and a translational oncology research grant reviewer.

I continually seek to gain a greater understanding of the advanced concepts and skills needed to initiate and sustain innovative biotechnology ventures.  I am sure that my interaction with y’all (I couldn’t resist adding a bit of Texas flavor) via the ‘The Transcript’ will be instrumental in helping to elevate my knowledge.

I look forward to connecting with everyone!

Leave a Reply